Clinical Trial Update: Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing the bioavailability of omeprazole 20 mg before and after bariatric surgery (morbid obesity) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bariatric Surgery-related Conditions
• Obesity

Drugs mentioned

• Omeprazole (Omeprazole)

Snippet

Sponsor: Emilio Vargas Castrillón | Conditions: Bariatric Surgery Candidate | Phase 4 | Status: COMPLETED